A detailed history of Hsbc Holdings PLC transactions in Pfizer Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 17,459,273 shares of PFE stock, worth $489 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
17,459,273
Previous 14,694,935 18.81%
Holding current value
$489 Million
Previous $423 Million 14.52%
% of portfolio
0.33%
Previous 0.37%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $71.6 Million - $82.2 Million
2,764,338 Added 18.81%
17,459,273 $484 Million
Q4 2023

Feb 12, 2024

BUY
$26.13 - $33.94 $57.4 Million - $74.6 Million
2,196,700 Added 17.58%
14,694,935 $423 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $2.04 Million - $2.39 Million
63,694 Added 0.51%
12,498,235 $415 Million
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $65 Million - $75.2 Million
1,798,740 Added 16.91%
12,434,541 $456 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $24 Million - $31.3 Million
-609,614 Reduced 5.42%
10,635,801 $434 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $103 Million - $135 Million
2,470,744 Added 28.16%
11,245,415 $576 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $11.5 Million - $14 Million
261,708 Added 3.07%
8,774,671 $387 Million
Q2 2022

Aug 11, 2022

BUY
$46.53 - $55.17 $8.5 Million - $10.1 Million
182,680 Added 2.19%
8,512,963 $444 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $4.13 Million - $5.12 Million
90,381 Added 1.1%
8,330,283 $434 Million
Q4 2021

Feb 11, 2022

SELL
$41.32 - $61.25 $41 Million - $60.7 Million
-991,112 Reduced 10.74%
8,239,902 $487 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $26.4 Million - $33.9 Million
-673,250 Reduced 6.8%
9,231,014 $399 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $32.4 Million - $36.7 Million
-901,066 Reduced 8.34%
9,904,264 $388 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $6.25 Million - $7.05 Million
-186,685 Reduced 1.7%
10,805,330 $391 Million
Q4 2020

Feb 25, 2021

SELL
$33.47 - $42.56 $10.5 Million - $13.4 Million
-314,107 Reduced 2.78%
10,992,015 $405 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $107 Million - $137 Million
3,209,872 Added 39.65%
11,306,122 $416 Million
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $18.1 Million - $21.3 Million
571,161 Added 7.59%
8,096,250 $297 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $12.8 Million - $15.6 Million
-426,074 Reduced 5.36%
7,525,089 $246 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $8.7 Million - $12.4 Million
-321,983 Reduced 3.89%
7,951,163 $260 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $32.2 Million - $36.5 Million
976,953 Added 13.39%
8,273,146 $323 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $11.7 Million - $15.1 Million
358,769 Added 5.17%
7,296,193 $262 Million
Q2 2019

Aug 13, 2019

BUY
$36.98 - $41.52 $27.2 Million - $30.5 Million
735,011 Added 11.85%
6,937,424 $301 Million
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $83.7 Million - $91.9 Million
-2,231,567 Reduced 26.46%
6,202,413 $263 Million
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $73.2 Million - $83.5 Million
-1,904,029 Reduced 18.42%
8,433,980 $368 Million
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $72.8 Million - $88.3 Million
2,110,962 Added 25.66%
10,338,009 $456 Million
Q2 2018

Aug 10, 2018

SELL
$32.98 - $35.16 $100 Million - $107 Million
-3,036,263 Reduced 26.96%
8,227,047 $298 Million
Q1 2018

May 11, 2018

SELL
$31.91 - $37.02 $42.5 Million - $49.4 Million
-1,333,248 Reduced 10.58%
11,263,310 $400 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $7.09 Million - $7.52 Million
213,125 Added 1.72%
12,596,558 $456 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $96.4 Million - $106 Million
3,109,844 Added 33.53%
12,383,433 $442 Million
Q2 2017

Aug 14, 2017

BUY
N/A
9,273,589
9,273,589 $312 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.